Clinical Trials Directory

Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

Conditions: Small Cell Lung Cancer

Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant...

Conditions: Breast Neoplasms

China

Resilience in Girls Victims of Sexual Abuse

Conditions: Child Sexual Abuse

Turkey

[Trial of device that is not approved or cleared by the U.S. FDA]

[Trial of device that is not approved or cleared by the U.S. FDA]

[Trial of device that is not approved or cleared by the U.S. FDA]

[Trial of device that is not approved or cleared by the U.S. FDA]

Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures

Conditions: Intertrochanteric Fractures

[Trial of device that is not approved or cleared by the U.S. FDA]

Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.

Conditions: Knee Osteoarthritis

The Process of Blood Collection With a Vascular Imaging Device

Conditions: Phlebotomy

Turkey

[Trial of device that is not approved or cleared by the U.S. FDA]

Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients

Conditions: Polymyalgia Rheumatica

[Trial of device that is not approved or cleared by the U.S. FDA]

Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort

Conditions: Rectal Cancer

Expanded Access to RBS2418

Conditions: Expanded Access

Position and Communication Skills Simulation

Conditions: Comparing to Effect Two Simulation Models

Turkey

Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transpla...

Conditions: Organ Transplantation, COVID-19

[Trial of device that is not approved or cleared by the U.S. FDA]

[Trial of device that is not approved or cleared by the U.S. FDA]

Early Access Program for ALXN1840 in Patients With Wilson Disease

Conditions: Wilson Disease

Residual or Recurrent Obstruction After Septal Myectomy

Conditions: Hypertrophic Obstructive Cardiomyopathy

[Trial of device that is not approved or cleared by the U.S. FDA]

Expanded Access to Epcoritamab

Conditions: Lymphoma